Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,558Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Boehringer Ingelheim (Canada) Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Empagliflozin

Brand Name : JARDIANCE

Patent Number : 2557801

Filing Date : 2005-03-11

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-11

Date Granted : 2013-06-25

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Empagliflozin

Brand Name : JARDIANCE

Patent Number : 2606650

Filing Date : 2006-05-02

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-05-02

Date Granted : 2014-02-11

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Empagliflozin

Brand Name : JARDIANCE

Patent Number : 2606650

Filing Date : 2006-05-02

Strength per Unit : 25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-05-02

Date Granted : 2014-02-11

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Empagliflozin

Brand Name : JARDIANCE

Patent Number : 2557801

Filing Date : 2005-03-11

Strength per Unit : 25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-11

Date Granted : 2013-06-25

blank